InvestorsHub Logo

Jhawker

12/21/16 9:56 AM

#166335 RE: nerby #166332

Nice find Nerby!

stevo99

12/21/16 9:01 PM

#166371 RE: nerby #166332

Wow over $28 Billion a year....maybe Purisol is worth $10 Billion....seems to me Pfizer might want a piece of this action....

"After decades of relatively unsuccessful treatment options, biologics came along to save the day with better efficacy. In the process, they’ve made billions of dollars for big pharma, with the likes of Humira by AbbVie (NYSE:ABBV), Remicade and Stelara by Johnson & Johnson (NYSE:JNJ) and Enbrel by Amgen (NYSE:AMGN) cumulatively generating about $28.5 billion in sales last year alone. While all those drugs are indicated for psoriasis, they also treat other diseases and conditions, such as forms of arthritis and Crohn’s."